UPDATE 1-AstraZeneca loses second top executive as Vectura gets new CEO
June 24, 2015 at 06:10 AM EDT
LONDON, June 24 (Reuters) - AstraZeneca has lost a second senior executive in a fortnight with the departure of its respiratory and inflammatory medicines head James Ward-Lilley to become chief executive of lung drug specialist Vectura.
